Pharmacologist with experience in pre-clinical cardiovascular research and oncology clinical trial data review and trend analysis, real-world data analysis to identify pre-symptomatic markers of Alzheimer’s disease for early diagnosis, and cardiac imaging data evaluation for cardiac risk assessment associated with ischemic diseases of heart and brain, and risky health lifestyles. Strong relationship builder with the ability to effectively communicate to interdisciplinary teams resulting in cross-functional collaborations leading to timely protocol designing of 3 Phase IIb/III studies including double-blinded, cross-over, and platform trials, successful database development for start-up & execution and close-out of 2 Phase III/IV studies.Excellent teamwork and conflict resolution skills demonstrated by collaborating with different line functions to achieve annual submission of program level documents to health authorities.
Listed skills include Western Blotting, Pharmacology, Research, Elisa, and 14 others.